RhuDex (AV 1142742) - Active Biotech, Dr Falk, Medigene
Medigene: Corporate Presentation (MediGene) - Jan 30, 2014 - Anticipated patent protection on compound family until 2024; Anticipated patent protection on salt until 2027; Anticipated extension of patent protection until 2032 
Anticipated patent expiry Immunology
http://www.medigene.com/sites/default/files/downloads/140109_corppresentation_januar_2014.pdf
 
Jan 30, 2014
 
.
 
2fa7ac19-3fa6-4e28-b568-39daccbe1816.jpg